COMP <GO>
PTHS vs EXOZ // 10Y YIELD & FRED MACRO BETA
Pelthos Therapeutics Inc. (NYSE) VS. eXoZymes Inc. (NASDAQ) • 15-METRIC TALLY: PTHS 1
— EXOZ 2
■ METRIC PARITY
LAST: $9.40 (-43.17%) • MKT CAP: $36.0M
macro-sensitivity
—
LAST: $4.13 (+0.49%) • MKT CAP: $38.4M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PTHS VS. EXOZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PTHS | EXOZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 76.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -17.45% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | PTHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 21.8 | 36.5 | -14.70 | EXOZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $36.0M | $38.4M | -$2.4M | EXOZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PTHS REV | EXOZ REV | PTHS GROSS % | EXOZ GROSS % | PTHS FCF | EXOZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.8M | $27.2M | 76.3% | — | -$22.7M | -$6.7M |
| FY 2024 | $21.2M | $16.6M | — | — | -$5.8M | -$8.9M |
| FY 2023 | $19.2M | $70.1K | — | — | -$981.0K | -$1.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PTHS // BETA —
EXOZ // BETA —